UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000053362 |
|---|---|
| Receipt number | R000060907 |
| Scientific Title | Nationwide survey on the use of basiliximab (genetical recombination) for prevention of acute rejection after transplantations |
| Date of disclosure of the study information | 2024/01/22 |
| Last modified on | 2025/10/28 14:14:26 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2024/01/16 10:58:19 | ||
| 2 | Update | 2024/02/09 09:33:58 | Target sample size |
|
| 3 | Update | 2024/02/09 09:35:12 | Research ethics review |
|
| 4 | Update | 2024/02/09 09:37:20 | Recruitment status Date of IRB |
|
| 5 | Update | 2024/02/09 09:40:35 | Institutions |
|
| 6 | Update | 2025/03/31 10:45:33 | Recruitment status Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2025/04/01 17:07:27 | Date analysis concluded |
|
| 8 | Update | 2025/10/28 14:14:26 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
